TITLE

Good deals for careful shoppers

AUTHOR(S)
Boswell, Clay
PUB. DATE
September 2006
SOURCE
ICIS Chemical Business;9/4/2006, Vol. 1 Issue 33, p30
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article presents information on several merger and acquisition deals in the global fine chemicals industry. Malladi Drugs and Pharmaceuticals, the largest manufacturer of pseudoephedrine hydrochloride in India, acquired Novus Fine Chemicals in Carlstadt, New Jersey, for around $23 million in 2005, gaining a foothold in the U.S. controlled-substances market. Perhaps the most striking recent deal is Towerbrook Capital Partners' acquisition of Clariant's pharmaceutical fine chemicals business for SF110 million (€70 million/$90 million), which dosed in June.
ACCESSION #
22388334

 

Related Articles

  • Private equity snags fine chemicals. MIRASOL, FELIZA // Chemical Market Reporter;5/8/2006, Vol. 269 Issue 18, p26 

    The article reports that Clariant has sold its pharmaceutical fine chemicals unit to TowerBrook Capital Partners, a private equity firm in Great Britain. According to the article, the deal is valued at $89 million. It adds that the trend reflects the efforts of several firms to survive since the...

  • Indian Firm Buys Novus Fine Chemicals. Scott, Alex // Chemical Week;5/25/2005, Vol. 167 Issue 18, p27 

    Reports on the acquisition of Novus Fine Chemicals by active pharma ingredients and pharmaceuticals firm Malladi Drugs and Pharmaceuticals. Details of the acquisition deal; Significance of the deal to Malladi.

  • THE WORLD THIS WEEK. Robinson, Simon // ICIS Chemical Business;7/10/2006, Vol. 1 Issue 27, p7 

    The article offers world news briefs related to the chemical industry. Bayer AG took further steps towards completing its €17 billion takeover of Schering AG. The European Court of First Instance upheld the €12.6 million fine levied by the European Commission against supplier Hoek...

  • Malladi Drugs acquires Novus Fine Chemicals.  // Chemical Market Reporter;5/23/2005, Vol. 267 Issue 21, p7 

    The article informs that Novus Fine Chemicals of Carlstadt, New Jersey, has been bought by Malladi Drugs and Pharmaceuticals, the largest manufacturer of ephedrine and pseudoephedrine salts in India. Once a Ganes Chemicals production site before being shed by Siegfried in a management buyout,...

  • Fine Chemicals Failures. Wood, Andrew // Chemical Week;5/3/2006, Vol. 168 Issue 15, p5 

    The article reports on the performance of the fine chemicals sector as of May 2006. Clariant announced that it is selling its pharma fine chemical operations to private equity capital firm TowerBrook Capital Partners. It is not just Clariant that made a slip-up in pharma fine chemicals. Rhodia...

  • Clariant Sells Pharmaceutical Fine Chemicals.  // China Chemical Reporter;5/16/2006, Vol. 17 Issue 14, p7 

    The article reports that Clariant AG has sold its Pharmaceutical Fine Chemicals SA unit to TowerBrook Capital Partners. The sale strengthens Clariant's strategy to focus its portfolio on core activities. Pharmaceutical Fine Chemicals is involved in the manufacture of building blocks, regulatory...

  • u.s. acquisitions abroad.  // Mergers & Acquisitions: The Dealermaker's Journal;Aug2006, Vol. 41 Issue 8, p73 

    The article offers information on U.S. acquisitions abroad in 2006. They include Texas Pacific Group Inc. and Mey Icki Sanayi Ltd., Pepsi Bottling Group Inc. and Bebidas Purificadas SA de CV, and TowerBrook Capital Partners LP and Clariant International AG.

  • Divestment in pharma field.  // Pharmaceutical Technology Europe;Jun2006, Vol. 18 Issue 6, p11 

    The article reports that Clariant has divested its Pharmaceutical Fine Chemicals business after attempts to reverse poor financial results had failed. The said business was bought by TowerBrook Capital. This follows the private equity firm's acquisition of another specialty chemical company,...

  • Jimmy Choo Begins New Chapter. Abel, Katie // FN: Footwear News;2/12/2007, Vol. 63 Issue 6, p4 

    The article reports on the new ownership of footwear company Jimmy Choo. The company could see big growth over the next several years with the addition of new categories and retail expansion. Jimmy Choo had been sold to TowerBrook Capital Partners LP, an international private equity firm in a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics